You just read:

Regeneron Presents Positive Data at ASH for REGN1979 CD20xCD3 Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

News provided by

Regeneron Pharmaceuticals, Inc.

Dec 01, 2018, 12:00 ET